About usServicesProductsContactSitemap

Health News & Updates

Menu
  Womens Clothing
  Adaptive Womens Clothing
  Mens Clothing
  Adaptive Mens Clothing
  Children & Teens Adaptive Clothing
  Adult Bibs & Clothing Protectors
  Plus Sizes (4X-5X-6X)
  Alzheimers Anti-Strip Jumpsuits
  Diabetic & Edema Socks
  Socks & Hoisery
  Shoes & Slippers
  Diabetic Shoes - Medicare Approved
  Incontinence Products
  Sensitive Skin Products
  Gifts & Accessories
  Gift Certificate
  Wheelchair/Walker Accessories
  Nurse Uniforms
  Name Labels
  New Items
Links
Product List
Home Page
CATALOG
Nursing Home Clothing Show
Nursing Home Wardrobe Tips
Health News & Updates
Size Measuring Tips
Shoe Measuring Tips
Easy Dressing Tips
Alzheimer's: Daily Care Tips
Alzheimer Dressing Tips
Arthritis: Footcare Tips
Diabetics: Foot Care Tips
Health Tips: Walking
MS Dressing Tips
Stroke: Learn the Symptoms
FREE! Uniform Offer
Personal Needs Account
Wholesale/Sales Rep Account
FAQ
Resources & Links
Testimonials
Privacy Policy
Return Policy
Contact Us
About Us
Check Out
Search




  

 

What Can you do to Minimize the effects of  Forgetfulness, Alzheimers or Dementia?

 

The expression “use it or lose it”   most often applies to physical muscle strength and tone. But over the past few years, research has demonstrated that this adage is equally true for mental strength and tone. The mind is also a “muscle” and it needs to be worked to stay healthy. To keep your mental faculties strong, you need to use your brain.

 

Latest Evidence:

A recent study showed that older adults who do volunteer work up to three hours a week live happier and healthier lives. Those in the test assessed themselves in three categories: how well they functioned handling daily activities, how they rated their own health and if they felt depressed. Volunteers had better scores than non- volunteers.

 

The important factor was doing the work. Being engaged in an activity that is meaningful and beneficial to others is a wonderful boost to the spirit and mind. Engagement is the key, not necessarily the hours of engagement.

According to researcher Jim Hinterlong , the lesson is that to stay mentally alert, exercise your brain. Volunteering is just one possibility. Reading , doing  puzzles, engaging in conversation, learning a musical instrument, painting, working on the computer-they all help to keep you on top of your mental game.

 

 

 

Bilingualism Delays Onset of Dementia

A new study from Ottawa, Canada found that people who are fully bilingual and speak both French and English every day for most of their lives can delay the onset of dementia by up to four years compared with those who only know one language.

Researchers said the extra effort involved in using more than one language appeared to boost blood supply to the brain and ensure nerve connection remained healthy- two factors thought to help fight off dementia. In the process of using two languages,  parts of your mind are being engaged and remain active. The brain needs that kind of constant exercise and activity.

 

The researchers determined that the mean age of onset of dementia symptoms in the monolingual group was 71.4 years while the bilingual group was 75.5 years.

The Alzheimer Society of Canada described the report as exciting and said it confirmed recent studies that showed that keeping the brain active was a good way to delay the impact of dementia.

The leading cause of dementia among the elderly is Alzheimer’s disease which gradually destroys a person’s memory. “Anything that can stave off the time when the risk factor (for dementia) overcomes the defenses is wonderful news,” scientific director Jack Diamond told Rueters.

 

 

Want to Reduce Your Alzheimer's Risk?

At this time, there is no known way to prevent Alzheimer's disease.

While none of these products or substances have been proven to prevent Alzheimer's disease, researchers are studying the possibility that you may be able to reduce your risk of developing Alzheimer's disease or delay the onset of the disease by:

  • Taking a moderate amount of vitamin E and other antioxidants.
  • Increasing your intake of folic acid and vitamins B6 and B12 if you have elevated homocysteine levels.
  • Taking a daily dose of a nonsteroidal anti-inflammatory drug (NSAID), such as indomethacin, ibuprofen, naproxen sodium, or aspirin.
  • Taking statins which are used to lower cholesterol.

      Talk with your doctor before using any of these products to prevent Alzheimer's disease.

      As we learn more about the causes of Alzheimer's disease, we also may learn more about how to prevent the disease. Drugs currently in development to prevent the formation of neurofibrillary "tangles" or amyloid plaques that damage the nerve cells in the brain may someday be used in people who are at risk for Alzheimer's.

      Research into a vaccine for Alzheimer's disease is ongoing.

      STROKE

      More than 700,000 Americans suffer strokes annually. Stroke is the third leading cause of death in the country and causes more serious long-term disabilities than any other disease.

       

      New Stroke Therapy

      Some stroke patients can regain considerable function and strength in their 'bad' arm by doing repetitive tasks with it while restraining thier 'good' arm. This intensive therapy called CIMT or Constant Induced Movement Therapy, was developed by Dr. Edward Taub several years ago. It has been slow to be accepted as no long term studies were available to prove its benefits.

      The Journal of the American Medical Association has recently published the results of a year long study lead by Dr. Stephen L. Wolf of Atlanta's Emory University School of Medicine which confirms that with CIMT Therapy stroke patients whose arm strength has been reasonably preserved can be trained to do tasks 34% more efficiently.

      CIMT Therapy is a two week treatment, at a cost of about $5000. The procedure is not yet covered by Medicare, but Dr. Wolf hopes that as a result of this promising report it will soon be approved, thereby allowing more stroke patients access to it.

       

      Robotic Therapy Helps Restore Hand Use After Stroke

      According to a Universiy of California, Irvine study, a robotice device may help people regain strength and normal use of the affected hand long after a stroke.

      Thirteen stoke victims participated in the pilot study by receiving 15 two-hour therapy sessions spread over a three week period. After therapy sessions using the Hand-Wrist Assisting Robotic Device (HOWARD), stroke patients with impaired hand use reported improved ability to grasp and release objects.

      The robotic device wraps around the hand and directs patients through a computerized physical therapy program. HOWARD users must initiate hand motion,  thereafter the robot helps complete the task so that the brain relearns what it's like to make the full movement. Robot-assisted therapy may help 'rewire' the brain and make weak limbs move better.

      The UCI team members are now using what they learned from the HOWARD study to improve the therapy with more hand-robot connections and more software option to help individualize the therapy for different stroke related situations.

       

       High dose of Vitamin D may Help Prevent Falls in the Elderly.

      That finding comes from a study of 124 residents of a Boston nursing home.

      The study shows that residents who took a daily dose of 800 international units (IU) of vitamin D for five months were less likely to fall than those who took either lower doses or no vitamin D.

      "Ensuring that nursing home residents are receiving adequate daily supplemental vitamin D may reduce the number of falls in elderly nursing home residents and could potentially reduce the risk of fracture in this high-risk group," write the researchers.

      They included Kerry Broe, MPH, of the Institute for Aging Research at Hebrew SeniorLife in Massachusetts. Hebrew SeniorLife operates senior health care, housing, research, and education in the Boston area.

      The study appears in the Journal of the American Geriatrics Society.

      About Vitamin D

      Vitamin D acts in the body as a hormone. Its tasks include keeping bones strong by boosting their calcium absorption.

      Vitamin D may also help muscle function, Broe's team notes.

      The body makes vitamin D when exposed to sunlight. But that ability fades with age, leaving older adults at risk of vitamin D deficiency.

      Vitamin D is also found in some foods, including milk fortified with vitamin D, cod liver oil, salmon, tuna, and eggs.

      Participants in Broe's study were 89 years old, on average. Most were white women. All lived at a long-term care facility run by Hebrew SeniorLife.

      Sixty-two percent of the group had fallen in the year before the study.

      When the study started, 63% of participants were taking a multivitamin. But 57% of the entire group -- and 54% of those taking a multivitamin -- had low blood levels of vitamin D.

      Vitamin D Supplements

      Participants were randomly assigned to take vitamin D or an empty pill (placebo) for five months.

      Those taking vitamin D were given one of four daily doses: 200 international units (IU), 400 IU, 600 IU, or 800 IU.

      No one knew what dose they were taking, or whether they were taking the placebo.

      Participants were allowed to keep taking multivitamins during the study, if they wanted to, but the researchers didn't supply anyone with multivitamins.

      Currently, the Institute of Medicine says 600 IU of vitamin D per day is "adequate" for men and women 71 or older.

      Residents' Falls

      The nursing home was required to keep records of residents' falls. During the five-month study, 61 participants (59%) suffered falls.

      The group taking 800 IU of vitamin D daily was the only one to show a reduced fall risk. They were 72% less likely to fall during the study period than those taking the placebo.

      None of the other vitamin D doses were associated with reduced falls.

      These results held when the researchers took age, BMI (body mass index), and other factors into account.

      People can fall for many reasons; and it's not certain vitamin D was the sole reason for the drop in falls for residents taking 800 IU of vitamin D daily.

      While the data doesn't show how much vitamin D participants got from their diet or sunshine, intake from those sources was probably "minimal," write the researchers.

      Too Much of a Good Thing?

      Vitamin D is one vitamin you shouldn't overdo. The body stores vitamin D in fat, and it can be unhealthy to let too much of the vitamin build up in the body.

      The tolerable upper limit for daily vitamin D intake is 2,000 IU for adults 19 and older, according to Institute of Medicine standards.

      Sunshine and diet are much less likely to cause excessive vitamin D levels than supplements, unless you're consuming lots of cod liver oil, according to the Office of Dietary Supplements, part of the National Institutes of Health.

      None of the nursing home residents had excessive vitamin D levels during the study.

      SOURCES: Broe, K. Journal of the American Geriatrics Society, February 2007; vol 55: pp 23-239. Office of Dietary Supplements, National Institutes of Health: "Dietary Supplement Fact Sheet: Vitamin D." News release, Blackwell Publishing.

      Pregnancy Hormone May Help Treat MS

      Hormone, Called Prolactin, Might Spur Repair of Nerve Damage in Multiple Sclerosis

      Feb. 23, 2007 -- Prolactin, a pregnancy hormone, may repair nerve damage and might help treat multiple sclerosis (MS), Canadian researchers report.

      So far, the scientists -- who work at the University of Calgary -- have only studied prolactin in female mice, not in people.

      But they note that MS symptoms often ease in human pregnancy, possibly because of prolactin.

      If so, prolactin could hold promise as a treatment for MS, note the researchers, who included Samuel Weiss, PhD.

      In multiple sclerosis, the body's immune system attacks the fatty sheath, called myelin, that protects nerves in the brain and spinal cord.

      "It was thought that during pregnancy, [women's] immune systems no longer destroyed the myelin," Weiss says in a Society for Neuroscience news release.

      "But no previous study has tested whether pregnancy actually results in the production of new myelin, which may explain improvement of symptoms," Weiss adds.

      Mouse Tests

      Weiss and colleagues studied pregnant and virgin female mice with damage to their myelin.

      They found that pregnant mice had both more prolactin and myelin-producing cells than the virgin mice.

      The pregnant mice also did better at repairing their myelin damage than the virgin mice, the study shows.

      Next, the scientists injected prolactin into virgin mice. Afterwards, the virgin mice boosted their number of myelin-producing cells and improved their ability to repair myelin damage.

      If the findings are confirmed in further studies, prolactin may prove useful in treating MS, note Weiss and colleagues.

      However, they suggest that since prolactin can increase inflammation, it might need to be combined with anti-inflammatory medicine.

      The study appears in The Journal of Neuroscience.

      SOURCES: Gregg, C. The Journal of Neuroscience, Feb. 21, 2007; vol 27: pp 1812-1823.

    • April 29, 2008 -- An experimental new drug may help people with mild disease by slowing the functional decline of the disease.

      The results are only preliminary, but a new phase II clinical study shows that people with mild Alzheimer's disease who took the drug Flurizan experienced a 46% slower decline in performing their normal daily activities and a 36% slower decline in overall function after a year of treatment compared with those who took the placebo. However, there was no significant effect on cognition.

      Flurizan is part of a new group of drugs under investigation in the treatment of Alzheimer's disease called selective amyloid-beta lowering agents (SALAs). The drugs work by targeting the buildup of amyloid-beta proteins in the brain, which is implicated in the brain damage associated with Alzheimer's.

      Although experts are quick to point out that the drug is no miracle cure for Alzheimer's disease, the results were promising enough for the drug's manufacturer, Myriad Pharmaceuticals, to pursue further, phase III clinical trials.

      "Do these results prove the efficacy of [Flurizan] in slowing decline in AD? No -- the data are consistent with a beneficial effect of [Flurizan] in mild AD, but are hardly conclusive," writes Paul Aisen, MD, of the University of California, in San Diego, in an editorial that accompanies the study in the Lancet.

      "With the need so enormous, and the potential effect of the benefit suggested (although not proven) by these phase II results, the effort is indeed justified despite the substantial uncertainty," Aisen writes. "In a few months, we will learn whether [Flurizan] will be the first anti-amyloid intervention to be efficacious in a pivotal trial."

      Alzheimer's Drug Benefits Those in Early Stages

      In the study, researcher Gordon Wilcock, BCh, a professor of medicine at Oxford University in England, and colleagues evaluated the effect of Flurizan in 210 people with mild to moderate Alzheimer's disease.

      The participants were divided into groups that received either 400 milligrams or 800 milligrams of Flurizan or a placebo twice a day for a year. After the year of treatment, participants were also invited to continue treatment for another 12 months. Those previously on placebo were randomly assigned to take either the 400 milligram dose or 800 milligram dose twice a day in the second 12 months.

      The results show that people with mild Alzheimer's disease who took the higher dose experienced slower rates of decline in activities of daily living and overall function compared with those who took the placebo.

      However, the overall rate of Alzheimer's-related mental decline did not differ significantly between the treatment groups.

      In people with moderate Alzheimer's disease, neither treatment dose of Flurizan had any significant effect on the progression of the disease.

      Overall, researchers say the study shows the 800 milligram dose was well tolerated for up to two years of treatment and merits further study in a larger, phase III clinical trial. The most common side effects were, vomiting,nausea and dizziness, which were reported at similar levels among all treatment groups, the researchers write.

      SOURCES:Wilcock, G. The Lancet Neurology, April 30, 2008, online edition. News release, The Lancet.

    • Alzheimer's Association-National health organization supporting Alzheimer's research, programs and services.   www.alz.org

      American Association of Retired Persons-AARP-www.aarp.org

      American Diabetes Association: www.diabetes.org

      American Heart Association: www.americanheart.org

      American Parkinson's Disease Association-www.apdaparkinson.org

      Arthritis Foundation- www.arthritis.org

      Brain Injury Association of America-www.biausa.org

      Medicare:Information on Programs & Benefits-www.medicare.gov

      National Institute on Aging:Health and research info-www.nia.nih.gov

       Social Security Administration:Information & Benefits- www.ssa.gov


    • About us | Catalog | Products | Contact | Sitemap

      © Adaptive Clothing Showroom LLC. All rights reserved.